Quarterly report [Sections 13 or 15(d)]

Segment Reporting (Details)

v3.25.1
Segment Reporting (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
USD ($)
segment
Mar. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
Segment Reporting [Abstract]      
Number of reportable segments (segment) | segment 1    
Segment Reporting Information [Line Items]      
Medical expense $ (372,043) $ (382,057)  
Total (43,173) (47,534)  
Tax benefit (1,073) (2,072)  
Net loss (44,246) (49,606)  
TOTAL ASSETS [1] 783,870   $ 783,420
Single Reportable Segment [Member]      
Segment Reporting Information [Line Items]      
Revenue from Contract with Customer, Including Assessed Tax 373,225 388,488  
Medical expense (352,317) (347,582)  
Depreciation, Depletion and Amortization (21,052) (21,539)  
Other Cost and Expense, Operating (14,900) (28,561)  
Interest Expense, Operating (8,725) (4,256)  
Interest Income, Operating 322 391  
Total (43,173) (47,534)  
Tax benefit (1,073) (2,072)  
Net loss (44,246) (49,606)  
TOTAL ASSETS 129,350   $ 121,266
Other Medical Expenses $ (19,726) $ (34,475)  
[1] The Company’s condensed consolidated balance sheets include the assets and liabilities of its consolidated variable interest entities (“VIEs”). As discussed in Note 13 “Variable Interest Entities,” P3 LLC is itself a VIE. P3 LLC represents substantially all the assets and liabilities of the Company. As a result, the language and amounts below refer only to VIEs held at the P3 LLC level. The condensed consolidated balance sheets include total assets that can be used only to settle obligations of P3 LLC’s consolidated VIEs totaling $10.7 million and $9.3 million as of March 31, 2025 and December 31, 2024, respectively, and total liabilities of P3 LLC’s consolidated VIEs for which creditors do not have recourse to the general credit of the Company totaled $15.6 million and $14.9 million as of March 31, 2025 and December 31, 2024, respectively. These VIE assets and liabilities do not include $41.1 million and $40.3 million of net amounts due to affiliates as of March 31, 2025 and December 31, 2024, respectively, as these are eliminated in consolidation and not presented within the condensed consolidated balance sheets.